Results 191 to 200 of about 5,643 (237)

High-grade gliomas associated with neurofibromatosis type 1: analysis of imaging features and literature review. [PDF]

Pol J Radiol
Vijan A, Nair SM, Sahu A, Chopade P, Sridhar E, Jain A, Chatterjee A, Choudhari A, Prasad M, Chinnaswamy G, Singh V, Shetty P, Dasgupta A, Moiyadi A, Gupta T, Goda JS.   +15 more
europepmc   +1 more source

Faculty Opinions recommendation of H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis.

, 2019
Jason T. Huse
openalex   +2 more sources

Applications of artificial intelligence and advanced imaging in pediatric diffuse midline glioma. [PDF]

Neuro Oncol
Haddadi Avval A, Banerjee S, Zielke J, Kann BH, Mueller S, Rauschecker AM.   +5 more
europepmc   +1 more source

Diffuse midline glioma, H3K27-altered, mimicking central neurocytoma on MRI: A case report. [PDF]

Radiol Case Rep
Kojita Y, Kanda T, Yokoo S, Yasuda K, Miyazaki T, Zeng F, Jimbo N, Sasayama T, Murakami T.   +8 more
europepmc   +1 more source

H3K27M-mutant spinal cord and hemispheric tumor with prolonged survival: illustrative case. [PDF]

J Neurosurg Case Lessons
Liu E, Su HM, Toyota P, Newton BD, Coote N, Marciniuk K, Auer RN, Fourney DR.   +7 more
europepmc   +1 more source

CAR T cells targeting the glycoprotein GD2 show potent antitumor efficacy in high-risk ependymoma models. [PDF]

J Clin Invest
Tallon-Cobos AC, Vazaios K, Waranecki P, van Hoesel M, Cornel A, Schwalm B, Mack N, de Boed E, van der Lugt J, Nierkens S, Kool M, Hoving EW, Metselaar DS, Hulleman E.   +13 more
europepmc   +1 more source

Table S2 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, Sebastian M. Waszak, Stefan R. Sweha, Mateus Mota, Matthew Pun, Akash Deogharkar, Chan Chung, Rohinton S. Tarapore, Samuel Ramage, Andrew Chi, Patrick Y. Wen, Isabel Arrillaga‐Romany, Tracy T. Batchelor, Nicholas Butowski, Ashley Sumrall, Nicole Shonka, Rebecca A. Harrison, John de Groot, Minesh P. Mehta, Matthew D. Hall, Doured Daghistani, Timothy F. Cloughesy, Benjamin M. Ellingson, Kévin Beccaria, Pascale Varlet, Michelle M. Kim, Yoshie Umemura, Hugh Garton, Andrea Franson, Jonathan Schwartz, Rajan Jain, Maureen Kachman, Heidi Baum, Charles Burant, Sophie L. Mottl, Rodrigo T. Cartaxo, Vishal John, Dana Messinger, Tingting Qin, Erik Peterson, Peter Sajjakulnukit, Karthik Ravi, Alyssa Waugh, Dustin Walling, Yujie Ding, Ziyun Xia, Anna Schwendeman, Debra Hawes, Fusheng Yang, Alexander R. Judkins, Daniel Wahl, Costas A. Lyssiotis, Daniel de la Nava, Marta M. Alonso, Augustine Eze, Jasper Spitzer, Susanne V. Schmidt, Ryan J. Duchatel, Matthew D. Dun, Jason E. Cain, Li Jiang, Sylwia A. Stopka, Gerard Baquer, Michael S. Regan, Mariella G. Filbin, Nathalie Y.R. Agar, Lili Zhao, Chandan Kumar‐Sinha, Rajen Mody, Arul M. Chinnaiyan, Ryo Kurokawa, Drew Pratt, Viveka Nand Yadav, Jacques Grill, Cassie Kline, Sabine Mueller, Adam Resnick, Javad Nazarian, Joshua E. Allen, Yazmín Odia, Sharon L. Gardner, Carl Koschmann   +83 more
openalex   +1 more source

Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas

, 2018
Drew Pratt, Siva Kumar Natarajan, Adam Banda, Caterina Giannini, Pankaj Vats, Carl Koschmann, Rajen Mody, Arul M. Chinnaiyan, Sriram Venneti   +8 more
openalex   +2 more sources

Initial Endoscopic Ventricular Failure to Relieve Hydrocephalus in Patients With Obstructing Brain Tumors Predicts a Histone 3K27M Mutation. [PDF]

Cureus
Shields LB, Daniels MW, Coombs L, Vaynerman A, Sinicrope K, Barbour M, Spalding A, Gump W, Mutchnick I, Sun D.   +9 more
europepmc   +1 more source

Aberrant histone modifications in pediatric brain tumors. [PDF]

Front Oncol
Hamanishi ET, Dang D, Venneti S.
europepmc   +1 more source